Connor, Clark & Lunn Investment Management Ltd.
Position in PBYI — Puma Biotechnology, Inc.
CIK 1596800
VANCOUVER, A1
Position in PBYI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,002,079
-$205,961 QoQ
Shares Held
782,798
-10.6% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $669,981,685 across 100 Biotechnology names. PBYI ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
516,108 | $16,794,154 |
All Filings in PBYI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,002,079 | 782,798 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,208,040 | 875,301 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,009,836 | 943,472 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,087,878 | 900,256 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,461,799 | 831,689 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,486,472 | 487,368 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $939,560 | 368,455 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,155,715 | 354,514 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,045,073 | 385,863 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $851,533 | 196,659 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $525,387 | 199,767 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $705,177 | 199,767 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $568,390 | 183,945 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $775,232 | 183,270 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $353,826 | 149,294 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $221,134 | 77,591 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $261,305 | 90,731 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $304,653 | 100,215 | Shares | Sole | 2022-02-10 | |
| 2020-03-31 | $96,781 | 11,467 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||